Diagnostic Value of Fecal Calprotectin in Disorders of the Upper Gastrointestinal Tract

Value of Fecal Calprotectin in Upper Gastrointestinal Disease

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00920400

Enrollment

287

Registered

2009-06-15

Start date

2008-03-31

Completion date

2009-12-31

Last updated

2010-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Dyspepsia, Inflammatory Bowel Diseases, Irritable Bowel Syndrome, Peptic Esophagitis, Peptic Ulcer

Brief summary

Fecal calprotectin is a very sensitive non-invasive inflammation marker in the detection of inflammatory bowel disease and, to a lesser degree, has also proven to be useful in adenomatous polyps, neoplasias, and infectious gastroenteritis. Elevated calprotectin levels can also be found in patients with lesion only in the upper gastrointestinal tract. However, the diagnostic value of calprotectin has never been tested in this setting. The aim of the study is therefore to determine the diagnostic value of fecal calprotectin in patients with diseases of the upper gastrointestinal tract.

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* All patients referred for upper gastrointestinal endoscopy for any reason * Older than 18 years

Exclusion criteria

* Patients who are not able to provide informed consent * Patients who are not able to provide a stool sample

Countries

Switzerland

Outcome results